Upregulated miR-18a expression decreases interferon regulatory factor 2 (IRF2) activity leading to decreased cell apoptosis and enhanced cell proliferation in NSCLC tumor cells [94]. This evidence concerns the gene IRF2 and non-small cell lung carcinoma.